Friday, October 9, 2015: 7:00 AM-8:15 AM
Room: 25--ABC
Co-organized with the National Institute of Allergy and Infectious Diseases
Learning Objectives:
At the conclusion of this session, participants will be able to:
- recognize the importance of antifungal stewardship in clinical practice
- describe the measures that can be taken to implement antifungal stewardship in clinical practice
Target Audience: Public health practitioners, Researchers, Pharmacists, Microbiologists, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians
Tracks: Pediatric ID, HIV-STD-TB, Epidemiology and Infection Control, Adult ID
Moderators:
Eleftherios Mylonakis, MD, PhD, FIDSA, Rhode Island Hospital
and
Michail Lionakis, MD, ScD, National Institutes of Health
Presentations:
CME Credits: Maximum of 1.25 hours of
AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-164-L04-P
Disclosures:
E. Mylonakis,
T2 biosystems:
Grant Investigator
,
Research grant
Astellas Pharma:
Board Member
and
Grant Investigator
,
Consulting fee
and
Grant recipient
Boehringer Ingelheim:
Grant Investigator
,
Research grant
M. Lionakis,
None